Ignite Creation Date:
2025-12-24 @ 11:14 PM
Ignite Modification Date:
2026-01-05 @ 5:23 PM
Study NCT ID:
NCT06033469
Status:
UNKNOWN
Last Update Posted:
2024-06-14
First Post:
2023-09-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Therapeutic Monitoring of Infliximab and Adalimumab
Sponsor:
IRCCS Burlo Garofolo
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
RC 01/17
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None